+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spirometer Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5798014
The global spirometer market value in 2022 was USD 886.9 million driven by the increasing prevalence of respiratory diseases across the globe. The market size is anticipated to grow at a CAGR of 10.7% during the forecast period of 2023-2031 to achieve a value of USD 2,214.1 million by 2031.

Spirometer Introduction

A spirometer is a medical device used to measure lung function by assessing the volume and flow of air a person can inhale and exhale. Spirometry is a crucial diagnostic tool for identifying and monitoring respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and emphysema. Spirometers are commonly used in hospitals, clinics, and home care settings, helping healthcare professionals and patients manage respiratory conditions and track treatment progress.

The global spirometer market is witnessing significant growth due to factors such as the increasing prevalence of respiratory diseases, the growing geriatric population, rising awareness of respiratory health, and technological advancements in spirometry devices. The development of portable and connected spirometers has expanded the market's reach, enabling remote patient monitoring and facilitating timely diagnosis and treatment of respiratory conditions.

Spirometer Market Scenario

The global spirometer market is poised for significant growth as the demand for effective diagnostic tools for respiratory conditions continues to rise. Factors such as the increasing prevalence of respiratory diseases, technological advancements in spirometry devices, and growing awareness of respiratory health contribute to the market's expansion. The market is characterized by regional dynamics shaped by healthcare infrastructure, government support, and investment in research and development. However, challenges such as the high cost of advanced spirometers, limited access to diagnostic tools in low- and middle-income countries, and the need for skilled professionals to operate spirometers may impact market growth.

North America: The largest market for spirometers, driven by factors such as advanced healthcare infrastructure, the presence of major medical device companies, and a high prevalence of respiratory disorders.

Europe: The second-largest market, with increasing demand for spirometers due to a growing elderly population, government support, and an expanding healthcare sector.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing population, increasing prevalence of chronic respiratory diseases, and growing investments in healthcare infrastructure and research.

Spirometer Market Segmentations

Market Breakup by Product Type

  • Table-Top Spirometer
  • Hand-Held Spirometer
  • PC Based Spirometer

Market Breakup by Technology

  • Volume Measurement Spirometer
  • Flow Measurement Spirometers
  • Peak Flow Management

Market Breakup by Applications

  • Asthma
  • Chronic Obstructive Pulmonary Diseases (COPD)
  • Cystic Fibrosis
  • Pulmonary Fibrosis
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Spirometer Market

Some key trends of the market are as follows:
  • Increasing prevalence of respiratory diseases: The rising incidence of respiratory diseases, such as asthma and COPD, is driving the demand for effective diagnostic tools like spirometers
  • Technological advancements: The introduction of advanced spirometers with features such as portability, wireless connectivity, and user-friendly interfaces has improved the adoption of spirometry in various healthcare settings
  • Growing awareness of respiratory health: Increased awareness about the importance of respiratory health and early diagnosis of respiratory conditions is driving the demand for spirometers

Spirometer Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • SCHILLER AG
  • Henry Schein, Inc
  • ICU Medical, Inc
  • Koninklijke Philips N.V
  • MGC DIAGNOSTICS CORPORATION
  • Sibel, S.A.U
  • Fukuda Sangyo Co. Ltd
  • Medicare Systems
  • Lab Tech
  • Vitalograph

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Spirometer Market Overview
3.1 Global Spirometer Market Historical Value (2016-2022)
3.2 Global Spirometer Market Forecast Value (2023-2031)
4 Global Spirometer Market Landscape
4.1 Global Spirometer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Spirometer Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Spirometer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Spirometer Market Segmentation
6.1 Global Spirometer Market by Product Type
6.1.1 Market Overview
6.1.2 Table-Top Spirometer
6.1.3 Hand-Held Spirometer
6.1.4 PC Based Spirometer
6.2 Global Spirometer Market by Technology
6.2.1 Market Overview
6.2.2 Volume Measurement Spirometer
6.2.3 Flow Measurement Spirometers
6.2.4 Peak Flow Management
6.3 Global Spirometer Market by Applications
6.3.1 Market Overview
6.3.2 Asthma
6.3.3 Chronic Obstructive Pulmonary Diseases (COPD)
6.3.4 Cystic Fibrosis
6.3.5 Pulmonary Fibrosis
6.3.6 Others
6.4 Global Spirometer Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Homecare Settings
6.4.5 Others
6.5 Global Spirometer Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Spirometer Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Spirometer Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Spirometer Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Spirometer Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Spirometer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 SCHILLER AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Henry Schein, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ICU Medical, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Koninklijke Philips N.V.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 MGC DIAGNOSTICS CORPORATION
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Sibel, S.A.U.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Fukuda Sangyo Co. Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medicare Systems
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Lab Tech
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Vitalograph
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Spirometer Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Schiller AG
  • Henry Schein, Inc.
  • Icu Medical, Inc.
  • Koninklijke Philips N.V.
  • Mgc Diagnostics Corporation
  • Sibel, S.A.U.
  • Fukuda Sangyo Co. Ltd.
  • Medicare Systems
  • Lab Tech
  • Vitalograph

Methodology

Loading
LOADING...

Table Information